[{"id":"54a84071-c2ad-487e-b24d-56980071bc66","acronym":"","url":"https://clinicaltrials.gov/study/NCT02068794","created_at":"2021-01-18T09:31:44.594Z","updated_at":"2024-07-02T16:34:26.660Z","phase":"Phase 1/2","brief_title":"MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer","source_id_and_acronym":"NCT02068794","lead_sponsor":"Mayo Clinic","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MV-NIS"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 34","initiation":"Initiation: 03/31/2014","start_date":" 03/31/2014","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-06-13"},{"id":"100df7a9-71f2-4628-80e7-56222961276b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02962167","created_at":"2021-01-19T13:11:56.112Z","updated_at":"2024-07-02T16:35:13.720Z","phase":"Phase 1","brief_title":"Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT","source_id_and_acronym":"NCT02962167","lead_sponsor":"Sabine Mueller, MD, PhD","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MV-NIS"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 02/22/2017","start_date":" 02/22/2017","primary_txt":" Primary completion: 05/10/2023","primary_completion_date":" 05/10/2023","study_txt":" Completion: 05/10/2023","study_completion_date":" 05/10/2023","last_update_posted":"2024-03-20"},{"id":"080d2484-f210-4859-8c3f-f785a07ec913","acronym":"","url":"https://clinicaltrials.gov/study/NCT01846091","created_at":"2021-01-18T08:14:01.029Z","updated_at":"2024-07-02T16:35:55.578Z","phase":"Phase 1","brief_title":"Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer","source_id_and_acronym":"NCT01846091","lead_sponsor":"Mayo Clinic","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 positive • HER-2 negative • ER positive + PGR positive • PGR positive","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 negative • ER positive + PGR positive • PGR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MV-NIS"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 04/09/2013","start_date":" 04/09/2013","primary_txt":" Primary completion: 09/18/2019","primary_completion_date":" 09/18/2019","study_txt":" Completion: 11/26/2019","study_completion_date":" 11/26/2019","last_update_posted":"2023-02-14"},{"id":"9ace77ee-26e0-4b31-9e0b-c581eeadef9d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01503177","created_at":"2021-01-29T07:02:36.854Z","updated_at":"2024-07-02T16:36:36.304Z","phase":"Phase 1","brief_title":"Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma","source_id_and_acronym":"NCT01503177","lead_sponsor":"Mayo Clinic","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MV-NIS"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 11/01/2011","start_date":" 11/01/2011","primary_txt":" Primary completion: 04/11/2019","primary_completion_date":" 04/11/2019","study_txt":" Completion: 04/11/2019","study_completion_date":" 04/11/2019","last_update_posted":"2021-01-11"}]